Search Results - leon+bernal-mizrachi

2 Results Sort By:
Markers Predictive of Therapeutic Response in B-cell Malignancies
Application Test to detect NF-kB2 breaks to guide treatment with proteasome inhibitors and its use with other therapeutic agents. Key Benefits Improved the prediction model to determine which patients are more likely to respond to bortezomib treatment. Improved the efficacy of treatment for patients with multiple myeloma and lymphomas. Market...
Published: 7/30/2024   |   Inventor(s): Leon Bernal-Mizrachi
Keywords(s): Biomarker, Oncology
Category(s): TechPub Algolia > Diagnostics
NF-Kappa B Activity as a Predictor and Diagnostic for the Two Sub-Groups of Diffuse Large B Cell Lymphoma
Application Diagnostic assay that classifies non-Hodgkin's lymphoma specifically diffuse large B cell lymphoma (DLBCL) into two groups, which respond differently to chemotherapy. Key Benefits Uses gene expression profiling for classification. Provides classification of sub-group for a better selection of more specific and effective treatments. Market...
Published: 9/26/2024   |   Inventor(s): Leon Bernal-Mizrachi
Keywords(s): Oncology
Category(s): TechPub Algolia > Diagnostics